Last year's sponsor overviews:
BDD is a specialist drug formulation company providing expertise
across all areas of drug delivery.
We specialise in BDD Scintigraphy (gamma scintigraphy), a powerful and versatile technology used to demonstrate the in vivo behaviour of your formulation. This technique can be used to provide early real world evidence on formulation performance including: time and site of disintegration, gastric emptying, GI transit and in combination with pharmacokinetic data, provides a complete visualisation of formulation performance in man. This enhanced understanding of performance provides valuable clinical and marketable data.
BDD as experts in the field operate a rapid clinical package that can provide you with results from our Scintigraphic clinical trials within a 6 month timeframe.
Our patented time release technology OralogiK™ provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report and we aim to get results back to you within 6 months.
Life sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions for patients. Deloitte’s LS specialists understand the complexity of these challenges, and work with clients to drive progress and bring discoveries to life. We engage the breadth and depth of consulting services, plus the product development maturity of ConvergeHEALTH for comprehensive, integrated solutions to challenges and opportunities of the evolving health care ecosystem.
Together, we make it better.
As a marketer in the healthcare industry, you need to connect at a deep level with consumers. You need a message that resonates, informs and advises. With Epsilon Health, you can truly connect with your audience, creating meaningful conversations that inspire better healthcare choices. As we’re a part of Epsilon, we can unlock superior data and powerful insights for more targeted messaging. And our experience in the industry and expert medical team will make us the perfect partner for your brand.
ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence. With more than 45 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards.
Powered by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. Over the past four years, more than half of all FDA drug approvals came from ERT-supported studies. Pharma companies, Biotechs, and CROs have relied on ERT solutions in 9,500+ studies spanning three million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly – and with confidence. Go to ert.com or follow us on LinkedIn/Twitter.
Ignite Data design and deliver smarter research solutions in the Real-World using UK EHR and outcomes data.
We do this with powerful technology-enhanced solutions that allow us to efficiently and cost-effectively 'Find Sites', 'Recruit Patients' and 'Manage EHR Data' at key stages throughout the study lifecycle.
Our innovative model combines the latest technology with the best elements of traditional research processes and a growing network of digitally-contracted healthcare facilities.
Our clients include a wide range of leading pharmaceutical, CRO, SMO and NHS organisations.
Every project is different, so get in touch and we can discuss how best to add value to yours.
INC Research (Nasdaq: INCR) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries.
Kinapse provides expert advisory, capability building and operational services to the life sciences industries. Our expert teams partner with our clients to advise on strategy and operations, implement capability-building programs and deliver outsourced operational solutions. In Market Access, our mission is helping you organise to improve patient outcomes worldwide. At Kinapse we understand that healthcare systems are undergoing continuous change across the globe, constantly delivering new challenges that obstruct market access achievement and product uptake. Using our expertise and experience, we help our clients:
- Organisational strategy advisory
- Build industry-leading Market Access & HEOR structures and interfaces which support organisational, geographic and portfolio demands
- Product/market strategy advisory
- Help Value & Access matrix teams demonstrate positive patient, payer and health system benefits and secure uptake through the demonstration of healthcare product value, using Real World Evidence as well as traditional sources.
- Decision-support research & analysis
- Increase productivity through our global sourcing model to ensure client staff are able to concentrate on the most value-adding activities, and are freed from resource-intensive, routine tasks
With over 500 professionals worldwide, we select our teams to deliver the best possible solutions. Our deeply held values and operational processes drive our teams to ensure excellent client service on all our engagements.
QuintilesIMS is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles and IMS Health, QuintilesIMS’ approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes and enhanced clinical trial outsourcing through treatment innovations, care provision and access can leverage QuintilesIMS’ broad range of healthcare information, technology and service solutions to drive new insights and approaches.
QuintilesIMS provides solutions that span clinical to commercial bringing clients a unique opportunity to realize the full potential of innovations and advance healthcare outcomes.
As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes.
Synergus is a consulting company, which provides best-in-class services to Med Tech companies in Europe. We see our mission in improving healthcare by supporting the introduction of safe and cost-effective medical devices. We provide services in market access, health economics, epidemiology and evidence synthesis.
In addition to individual services, we provide access to number of unique European market intelligence tools, including databases of health technology assessment decisions, procedure volume and DRG tariffs.
Our team consists of experienced market access consultants, medical doctors, analysts, researchers, statisticians and medical writers, while our offices are located in Stockholm, Sweden and Paris, France. Being a small company we can offer excellent client management and fully customized approach to your needs.